Authorities are searching for Marwan Jumaa, a 20-year-old prisoner who escapes detention and is deemed a risk to the public. According to reports, Jumaa is serving a sentence linked to an attack on two women. Police messaging to the public warns people not to approach him. The manhunt is ongoing, with authorities treating him as potentially dangerous. One outlet reports that officials assess him as a risk both to himself and to others, while another emphasizes the threat to others and issues an explicit warning to the public not to get close if he is seen. The reports do not provide additional details on how he escaped, the exact location of the manhunt, or the current status of police efforts. Both sources agree on the identity of the escaped prisoner, the nature of the prior offence involving two women, and the precautionary guidance given to the public.
Manhunt for escaped prisoner Marwan Jumaa deemed risk to others
Authorities are searching for Marwan Jumaa, a 20-year-old prisoner who escapes detention and is deemed a risk to the public. According to reports, Jumaa is serving a sentence linked to an attack on tw...
- Marwan Jumaa, 20, escapes from custody and is the subject of a manhunt.
- Jumaa is serving a sentence related to an attack on two women.
- Authorities describe him as a risk to others.
- The public is warned not to approach him if seen.
- The search is ongoing, with police urging caution.
Marwan Jumaa was detained for attacking women, with the public warned "do not approach him".
3 hours agoMarwan Jumaa, 20, who is serving a sentence for attacking two women, was deemed to be a risk to himself and others.
3 hours ago
FDA approves first-of-its-kind cholesterol pill for high-risk patients
The U.S. Food and Drug Administration (FDA) approves a first-of-its-kind pill intended to lower cholesterol in patients...
Pamela Gwinnett arrested in Tenerife after fraud case involving pensioner
Pamela Gwinnett, a 63-year-old woman accused of scamming an 89-year-old pensioner in Lancashire, is arrested in Tenerife...
FDA approves Merck’s Lipfendra, a first once-daily oral PCSK9 inhibitor for high LDL
The U.S. Food and Drug Administration has approved Lipfendra (Merck) as a once-daily oral medication for lowering LDL (“...